|1.||Cole, Laurence A: 11 articles (08/2010 - 06/2002)|
|2.||Seckl, Michael J: 9 articles (11/2014 - 08/2006)|
|3.||Ngan, Hextan Y S: 8 articles (07/2015 - 08/2003)|
|4.||Cheung, Annie N Y: 8 articles (07/2015 - 08/2003)|
|5.||Siu, Michelle K Y: 7 articles (07/2015 - 10/2008)|
|6.||Murphy, Kathleen M: 5 articles (01/2012 - 09/2009)|
|7.||Ronnett, Brigitte M: 5 articles (01/2012 - 09/2009)|
|8.||Mak, Victor C Y: 4 articles (07/2015 - 04/2011)|
|9.||Wong, Esther S Y: 4 articles (07/2015 - 10/2008)|
|10.||Wong, Oscar G W: 4 articles (07/2015 - 04/2011)|
|1.||Neoplasm Metastasis (Metastasis)
12/01/2000 - "Patients with gestational trophoblastic disease (GTD) can usually achieve complete sustained remission while retaining their fertility even in the presence of wide-spread metastasis. "
05/01/2012 - "A retrospective descriptive study about the presence of metastases, epidemiological characteristics and treatment of 104 patients suffering from gestational trophoblastic disease was performed in the period from 1st Jan, 2000 to 31st December, 2010. "
02/01/2011 - "Pulmonary metastasis in patients with gestational trophoblastic disease."
03/01/2008 - "Gestational trophoblastic disease with painful skin metastases."
06/01/2002 - "A clinical diagnosis of persistent gestational trophoblastic disease (GTD) was made, based on quantitative serum beta-hCG of more than 200,000 IU/ml, cannon ball metastases on chest X-ray and two ring enhancing lesions, metastases, in the right parietal lobe on Computed Axial Tomography (CAT) scan of the brain. "
11/01/2014 - "The objective of this study was to provide a consensus review on gestational trophoblastic disease diagnosis and management from the combined International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup. "
01/01/2011 - "Gynecologic oncology involves the study of preinvasive disease and cancers of the vulva, vagina, cervix, uterus, ovaries, and gestational trophoblastic disease. "
09/01/1992 - "The study indicates that the Swedish Cancer Registry alone does not provide sufficient data for studies on the incidence of gestational trophoblastic disease."
12/01/2015 - "Gestational trophoblastic disease (GTD) is a term used for a group of pregnancy-related tumors. "
06/01/2008 - "Furthermore, it can be used as a biomarker for gestational trophoblastic disease (GTD), germ cell tumours and some non-trophoblastic gynaecological cancers and common epithelial tumours. "
07/30/1998 - "Subsequent study using immunohistochemistry showed high levels of DOC-2/hDab2 protein expression in normal trophoblast tissues but significantly lower levels of expression in gestational trophoblastic disease tissues, particularly in complete mole and choriocarcinoma. "
09/01/1990 - "[A clinicopathological study on gestational trophoblastic disease comparing with high risk criteria and diagnostic score of choriocarcinoma]."
09/01/2015 - "Gestational Trophoblastic Disease and Choriocarcinoma."
01/01/2015 - "Choriocarcinoma of the fallopian tube is a rare form of gestational trophoblastic disease. "
11/01/2014 - "Choriocarcinoma is the most aggressive, malignant form of gestational trophoblastic disease and has varying incidence, increasing in patients older than 40 years. "
|4.||Hydatidiform Mole (Molar Pregnancy)
01/01/2013 - "Previous studies indicate that epigenetic modifications play an important role in transcriptional regulation and contribute to the pathogenesis of gestational trophoblastic disease, including complete hydatidiform moles (CHMs). "
01/01/2012 - "Distinction of hydatidiform moles from nonmolar specimens and their subclassification as complete (complete hydatidiform mole) versus partial hydatidiform mole (PHM) are important for clinical practice and investigational studies to refine ascertainment of risk of persistent gestational trophoblastic disease, which differs among these entities. "
10/01/2011 - "Distinction of hydatidiform moles (HM) from nonmolar specimens and their subclassification as complete (CHM) versus partial hydatidiform mole (PHM) are important for clinical practice and investigational studies to refine ascertainment of risk of persistent gestational trophoblastic disease (GTD), which differs among these entities. "
07/01/2010 - "In the present study, we evaluated the incidence of postmolar gestational trophoblastic disease (GTD) in molar pregnancy. "
09/01/2009 - "Distinction of hydatidiform moles from nonmolar specimens and their subclassification as complete hydatidiform mole (CHM) versus partial hydatidiform mole (PHM) are important for clinical practice and investigational studies to refine ascertainment of risk of persistent gestational trophoblastic disease which differs among these entities. "
|5.||Arteriovenous Malformations (Arteriovenous Malformation)
07/01/2014 - "Uterine arteriovenous malformation after gestational trophoblastic disease: a report of two cases."
11/01/1991 - "Hysterectomy has been the treatment with symptomatic uterine arteriovenous malformations by means of transcatheter embolization; three of the lesions were related to gestational trophoblastic disease and one was congenital. "
09/01/2015 - "Uterine arteriovenous malformations are rare and have been reported to occur after uterine trauma (eg, surgery, gestational trophoblastic disease, malignancy). "
01/01/2014 - "Presence of increased uterine vascularity and arteriovenous shunting is non-specific and can be detected in a variety of conditions including retained trophoblastic tissue, gestational trophoblastic disease, arteriovenous malformation (AVM), placental polyp and vascular neoplasm. "
03/01/2014 - "The authors report the case of a patient with history of gestational trophoblastic disease and multiple curettage procedures who developed uterine arteriovenous malformations, with remission of the lesions after treatment with methotrexate. "
|2.||Etoposide (VP 16)
|6.||Proliferating Cell Nuclear Antigen (PCNA)
|7.||Keratin-20 (Cytokeratin 20)
|8.||Teniposide (VM 26)
|10.||Leucovorin (Folinic Acid)
|1.||Drug Therapy (Chemotherapy)
|4.||Bone Marrow Transplantation (Transplantation, Bone Marrow)